Maza, MauricioAlfaro, KarlaGarai, JillianVelado, Mario MoralesGage, Julia C.Castle, Philip E.Felix, JuanLuciani, SilvanaCampos, NicoleKim, JaneMasch, RachelCremer, Miriam2017-04-062017Maza, M., K. Alfaro, J. Garai, M. M. Velado, J. C. Gage, P. E. Castle, J. Felix, et al. 2017. “Cervical cancer prevention in El Salvador (CAPE)—An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.” Gynecologic Oncology Reports 20 (1): 58-61. doi:10.1016/j.gore.2017.02.011. http://dx.doi.org/10.1016/j.gore.2017.02.011.http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072141Highlights • CareHPV tests were used to compare screen-and-treat and colposcopy management. • Screen-and-treat strategy with HPV testing was found to be very cost-effective. • CAPE has screened > 25,000 women in the Paracentral region. • Over 70% of screen-positive women received recommended treatment within six months. • CAPE is an example of public-private partnership resulting in paradigm change.en-USHPVCervical cancerScreeningImplementationScreen-and-treatJournal Article2017-04-0610.1016/j.gore.2017.02.011